PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsCurrax Pharmaceuticals
Currax Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
OnzetraSumatriptan2016-01-272024-2036
Migraine disorders
,
Cluster headache
,
Juvenile arthritis
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Headache
,
Fever
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Back pain
,
Common cold
,
Toothache
,
Dysmenorrhea
,
Gout
SilenorDoxepin2010-03-172027-2030
Atopic dermatitis
,
Pruritus
,
Pain
,
Anxiety disorders
,
Psychotic affective disorders
,
Depressive disorder
TreximetNaproxen, Sumatriptan2008-04-152025-2026
Juvenile arthritis
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Headache
,
Fever
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Back pain
,
Common cold
,
Toothache
,
Dysmenorrhea
,
Gout
,
Gastroesophageal reflux
,
Helicobacter infections
,
Duodenal ulcer
,
Zollinger-ellison syndrome
,
Esophagitis
,
Heartburn
,
Nausea
,
Sleep initiation and maintenance disorders
,
Allergic rhinitis perennial
,
Urticaria
,
Motion sickness
,
Sneezing
,
Anxiety disorders
,
Sinusitis
,
Asthma
,
Stomach ulcer
,
Migraine disorders
,
Cluster headache
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Naproxen
knee osteoarthritis
,
hip osteoarthritis
,
osteoarthritis
,
menorrhagia
Sumatriptan
epilepsy
,
migraine disorders
Doxepin
ataxia
,
healthy volunteers/patients
Benzocaine
type 1 diabetes mellitus
,
healthy volunteers/patients
,
glycemic control
,
alzheimer disease
,
aggression
,
non-small-cell lung carcinoma
,
diabetic nephropathies
,
kidney diseases
,
diabetes mellitus
,
psychomotor agitation
,
fallopian tube neoplasms
,
ovarian epithelial carcinoma
,
neoplasms
,
head and neck neoplasms
,
recurrence
,
carcinoma
,
lung neoplasms
,
small cell lung carcinoma
,
adenocarcinoma of lung
,
bronchiolo-alveolar adenocarcinoma
,
atopic dermatitis
,
eczema
,
dermatitis
,
type 2 diabetes mellitus
,
alopecia areata
,
alopecia
,
migraine disorders
,
obesity
,
body weight
,
overweight
,
weight loss
,
hypertension
,
pulmonary hypertension
,
pulmonary arterial hypertension
,
connective tissue diseases
,
autoimmune diseases
,
systemic lupus erythematosus
,
depressive disorder
,
major depressive disorder
,
psoriasis
,
depression
,
osteoporosis
,
postmenopausal osteoporosis
,
diabetic neuropathies
,
bipolar disorder
Lorcaserin
healthy volunteers/patients
,
marijuana abuse
,
breast neoplasms
,
digestive system neoplasms
,
peripheral nervous system diseases
,
pharmacokinetics
,
liver diseases
,
hepatic insufficiency
,
renal insufficiency
,
cocaine-related disorders
,
tobacco use disorder
,
alcoholism
,
alcohol drinking
,
tobacco smoking
,
cannabis
,
sepsis
,
paresis
,
muscle weakness
,
asthenia
,
hypertension
,
dyslipidemias
,
sleep apnea syndromes
,
smoking cessation
,
opioid-related disorders
,
epilepsy
,
myoclonic epilepsies
,
substance-related disorders
,
obesity
,
weight loss
,
overweight
,
cardiovascular diseases
,
weight gain
,
body weight
,
schizophrenia
,
psychotic disorders
,
type 2 diabetes mellitus
,
diabetes mellitus
,
drug resistant epilepsy
Histone-arginine methyltransferase carm1
pain
,
diabetic neuropathies
Prudoxin
parkinson disease
,
carcinoma
,
breast neoplasms
,
dermatitis
,
radiodermatitis
,
neoplasms
,
non-small-cell lung carcinoma
,
thyroid neoplasms
,
esophageal neoplasms
,
lung neoplasms
,
sarcoma
,
lymphoma
,
second primary neoplasms
,
small cell lung carcinoma
,
thymoma
,
mesothelioma
,
thymus neoplasms
,
laryngeal neoplasms
,
hypopharyngeal neoplasms
,
irritable bowel syndrome
,
syndrome
,
psychophysiologic disorders
,
somatoform disorders
,
stomatitis
,
mucositis
,
dementia
,
schizophrenia
,
anxiety disorders
,
head and neck neoplasms
,
pain
,
urticaria
,
pruritus
,
sleep initiation and maintenance disorders
,
depression
,
atrophy
,
treatment-resistant depressive disorder
,
major depressive disorder
,
depressive disorder
,
hiv infections
,
ataxia
,
healthy volunteers/patients
,
drug-related side effects and adverse reactions
,
drug interactions
,
bipolar disorder
,
gastrointestinal diseases
,
dyspepsia
,
digestive system diseases
,
nasopharyngeal carcinoma
,
breakthrough pain
Lorcaserin hydrochloride anhydrous
obesity
Surlorian
pain
,
diabetic neuropathies
Lorcaserin hydrochloride hemihydrate
healthy volunteers/patients
,
marijuana abuse
,
breast neoplasms
,
digestive system neoplasms
,
peripheral nervous system diseases
,
pharmacokinetics
,
liver diseases
,
hepatic insufficiency
,
renal insufficiency
,
cocaine-related disorders
,
tobacco use disorder
,
alcoholism
,
alcohol drinking
,
tobacco smoking
,
cannabis
,
sepsis
,
paresis
,
muscle weakness
,
asthenia
,
hypertension
,
dyslipidemias
,
sleep apnea syndromes
,
smoking cessation
,
opioid-related disorders
,
epilepsy
,
myoclonic epilepsies
,
substance-related disorders
,
obesity
,
weight loss
,
overweight
,
cardiovascular diseases
,
weight gain
,
body weight
,
schizophrenia
,
psychotic disorders
,
type 2 diabetes mellitus
,
diabetes mellitus
,
drug resistant epilepsy
Isoxaflutole
diabetes mellitus
,
healthy volunteers/patients
,
type 2 diabetes mellitus
,
type 1 diabetes mellitus
,
postmenopause
,
cardiovascular diseases
,
metabolic diseases
,
obstructive sleep apnea
,
non-alcoholic fatty liver disease
,
metabolic syndrome
,
overweight
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use